{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:49:17Z","timestamp":1792259357952,"version":"4.4.0"},"reference-count":22,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.2176\/jns-nmc.2021-0426","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T22:15:28Z","timestamp":1653948928000},"page":"123-128","source":"Crossref","is-referenced-by-count":5,"title":["Primary Dural Mucosa-associated Lymphoid Tissue Lymphoma Mimicking Falx Meningioma: A Case Report"],"prefix":"10.2176","volume":"9","author":[{"given":"Issei","family":"TAKEUCHI","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"TANEI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"KUWABARA","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Laboratories, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"KATO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"NAITO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"KOKETSU","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"HIRAYAMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"HASEGAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Komaki City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Batchelor TT: Primary central nervous system lymphoma: A curable disease. <i>Hematol Oncol<\/i> 37: 15-18, 2019","DOI":"10.1002\/hon.2598"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Swerdlow SH, Campo E, Pileri SA, et al.: The 2016 revision of the World Health Organization classification of lymphoid neoplasms. <i>Blood<\/i> 127: 2375-2390, 2016","DOI":"10.1182\/blood-2016-01-643569"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS: Central nervous system manifestations of marginal zone B-cell lymphoma. <i>Ann Hematol<\/i> 89: 1003-1009, 2010","DOI":"10.1007\/s00277-010-0976-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kamoshima Y, Sawamura Y, Sugiyama T, Yamaguchi S, Houkin K, Kubota K: Primary central nervous system mucosa-associated lymphoid tissue lymphoma--case report. <i>Neurol Med Chir (Tokyo)<\/i> 51: 527-530, 2011","DOI":"10.2176\/nmc.51.527"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) La Rocca G, Auricchio AM, Mazzucchi E, et al.: Intracranial dural based marginal zone MALT-type B-cell lymphoma: a case - Based update and literature review. <i>Br J Neurosurg<\/i> 26: 1-7, 2021","DOI":"10.1080\/02688697.2021.1941760"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Razaq W, Goel A, Amin A, Grossbard ML: Primary central nervous system mucosa-associated lymphoid tissue lymphoma: case report and literature review. <i>Clin Lymphoma Myeloma<\/i> 9: E5-E9, 2009","DOI":"10.3816\/CLM.2009.n.052"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sunderland AJ, Steiner RE, Al Zahrani M, et al.: An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. <i>Cancer Med<\/i> 9: 663-670, 2020","DOI":"10.1002\/cam4.2732"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tu PH, Giannini C, Judkins AR, et al.: Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. <i>J Clin Oncol<\/i> 23: 5718-5727, 2005","DOI":"10.1200\/JCO.2005.17.624"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Brice P, Bastion Y, Lepage E, et al.: Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d&apos;Etude des Lymphomes Folliculaires. Groupe d&apos;Etude des Lymphomes de l&apos;Adulte. <i>J Clin Oncol<\/i> 15: 1110-1117, 1997","DOI":"10.1200\/JCO.1997.15.3.1110"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Khalil MO, Morton LM, Devesa SS, et al.: Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. <i>Br J Haematol<\/i> 165: 67-77, 2014","DOI":"10.1111\/bjh.12730"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sugita Y, Hashimoto G, Fukuda K, et al.: primary nondural central nervous system marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type mimicking CNS inflammatory diseases. <i>J Neuropathol Exp Neurol<\/i> 80: 789-799, 2021","DOI":"10.1093\/jnen\/nlab058"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sanchez ML, Almeida J, Gonzalez D, et al.: Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. <i>Blood<\/i> 102: 2994-3002, 2003","DOI":"10.1182\/blood-2003-01-0045"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Delville JP, Heimann P, El Housni H, et al.: Biclonal low grade B-cell lymphoma confirmed by both flow cytometry and karyotypic analysis, in spite of a normal kappa\/lambda Ig light chain ratio. <i>Am J Hematol<\/i> 82: 473-480, 2007","DOI":"10.1002\/ajh.20850"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Braunschweig R, Baur AS, Delacr\u00e9taz F, Bricod C, Benhattar J: Contribution of IgH-PCR to the evaluation of B-cell lymphoma involvement in paraffin-embedded bone marrow biopsy specimens. <i>Am J Clin Pathol<\/i> 119: 634-642, 2003","DOI":"10.1309\/NPQXQV82Q0R8VBKT"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Th\u00e9riault C, Galoin S, Valmary S, et al.: PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. <i>Mod Pathol<\/i> 13: 1269-1279, 2000","DOI":"10.1038\/modpathol.3880232"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ayanambakkam A, Ibrahimi S, Bilal K, Cherry MA: Extranodal marginal zone lymphoma of the central nervous system. <i>Clin Lymphoma Myeloma Leuk<\/i> 18: 34-37.e8, 2018","DOI":"10.1016\/j.clml.2017.09.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Chihara D, Fowler NH, Oki Y, et al.: Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis. <i>Oncotarget<\/i> 9: 28897-28902, 2018","DOI":"10.18632\/oncotarget.25622"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Iwamoto FM, Abrey LE: Primary dural lymphomas: a review. <i>Neurosurg Focus<\/i> 21: E5, 2006","DOI":"10.3171\/foc.2006.21.5.6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Puri DR, Tereffe W, Yahalom J: Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data. <i>Int J Radiat Oncol Biol Phys<\/i> 71: 1425-1435, 2008","DOI":"10.1016\/j.ijrobp.2007.12.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Karschnia P, Batchelor TT, Jordan JT, et al.: Primary dural lymphomas: Clinical presentation, management, and outcome. <i>Cancer<\/i> 126: 2811-2820, 2020","DOI":"10.1002\/cncr.32834"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Freedman A, Jacobsen E: Follicular lymphoma: 2020 update on diagnosis and management. <i>Am J Hematol<\/i> 95: 316-327, 2020","DOI":"10.1002\/ajh.25696"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Owen RG, Treon SP, Al-Katib A, et al.: Clinicopathological definition of Waldenstrom&apos;s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom&apos;s Macroglobulinemia. <i>Semin Oncol<\/i> 30: 110-115, 2003","DOI":"10.1053\/sonc.2003.50082"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/9\/0\/9_2021-0426\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T06:03:56Z","timestamp":1654322636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/9\/0\/9_2021-0426\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":22,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2021-0426","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]},"article-number":"2021-0426"}}